BMY Bristol Myers Squibb Co
Price (delayed)
$59.55
Market cap
$120.85B
P/E Ratio
N/A
Dividend/share
$2.42
EPS
-$4.41
Enterprise value
$160.15B
Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease,
Highlights
The company's revenue rose by 7% YoY
The quick ratio has decreased by 13% YoY but it has increased by 8% QoQ
Bristol Myers Squibb's equity has decreased by 44% YoY and by 4.7% from the previous quarter
BMY's debt is up by 25% year-on-year
Key stats
What are the main financial stats of BMY
Market
Valuations
Earnings
Shares outstanding
2.03B
Market cap
$120.85B
Enterprise value
$160.15B
Price to earnings (P/E)
N/A
Price to book (P/B)
7.39
Price to sales (P/S)
2.5
EV/EBIT
N/A
EV/EBITDA
132.79
EV/Sales
3.32
Revenue
$48.3B
Gross profit
$34.33B
Operating income
-$8.38B
Net income
-$8.95B
EBIT
-$8.39B
EBITDA
$1.21B
Free cash flow
$13.94B
Per share
Balance sheet
Liquidity
EPS
-$4.41
EPS diluted
-$4.41
Free cash flow per share
$6.87
Book value per share
$8.05
Revenue per share
$23.81
TBVPS
$23.46
Total assets
$92.6B
Total liabilities
$76.22B
Debt
$49.65B
Equity
$16.34B
Working capital
$6.01B
Debt to equity
3.04
Current ratio
1.25
Quick ratio
0.91
Net debt/EBITDA
32.59
Margins
Efficiency
Dividend
EBITDA margin
2.5%
Gross margin
71.1%
Net margin
-18.5%
Operating margin
-17.3%
Return on assets
-9.4%
Return on equity
-53.4%
Return on invested capital
-13%
Return on capital employed
-12.2%
Return on sales
-17.4%
Dividend yield
4.06%
DPS
$2.42
Payout ratio
N/A
BMY stock price
How has the Bristol Myers Squibb stock price performed over time
Intraday
-2.36%
1 week
0.61%
1 month
-0.12%
1 year
12.38%
YTD
5.29%
QTD
-2.36%
Financial performance
How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$48.3B
Gross profit
$34.33B
Operating income
-$8.38B
Net income
-$8.95B
Gross margin
71.1%
Net margin
-18.5%
The operating income has dropped by 199% year-on-year and by 22% since the previous quarter
The operating margin has dropped by 192% year-on-year and by 19% since the previous quarter
The net income has declined by 23% since the previous quarter
BMY's net margin is down by 21% since the previous quarter
Growth
What is Bristol Myers Squibb's growth rate over time
Valuation
What is Bristol Myers Squibb stock price valuation
P/E
N/A
P/B
7.39
P/S
2.5
EV/EBIT
N/A
EV/EBITDA
132.79
EV/Sales
3.32
Bristol Myers Squibb's EPS has decreased by 23% QoQ
BMY's P/B is 64% above its 5-year quarterly average of 4.5 and 19% above its last 4 quarters average of 6.2
Bristol Myers Squibb's equity has decreased by 44% YoY and by 4.7% from the previous quarter
The price to sales (P/S) is 17% less than the 5-year quarterly average of 3.0 but 14% more than the last 4 quarters average of 2.2
The company's revenue rose by 7% YoY
Efficiency
How efficient is Bristol Myers Squibb business performance
Bristol Myers Squibb's return on sales has shrunk by 193% YoY and by 20% QoQ
BMY's return on invested capital has dropped by 177% year-on-year and by 17% since the previous quarter
The ROE has contracted by 47% from the previous quarter
Bristol Myers Squibb's ROA has decreased by 24% from the previous quarter
Dividends
What is BMY's dividend history
DPS
$2.42
Dividend yield
4.06%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Bristol Myers Squibb financials performed over time
BMY's total assets is 22% greater than its total liabilities
The total liabilities has increased by 16% year-on-year
Bristol Myers Squibb's current ratio has decreased by 13% YoY
The company's debt to equity has surged by 125% YoY and by 4.8% QoQ
Bristol Myers Squibb's equity has decreased by 44% YoY and by 4.7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.